Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 52817-331

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 52817-331). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine HCl Tabs 10mg 1000s

Cyclobenzaprine HCl Tabs 10mg 1000s
Each film-coated tablet contains 10mg of Cyclobenzaprine hydrochloride USP. This medication is manufactured by Rubicon Research Private Limited, located in Ambernath, Dist. Thane, 421506 India, with manufacturing license number KD-682. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. It is recommended to keep the container tightly closed and out of the reach of children. The medication should be stored at 20°C to 25°C (68°F to 77°F) as defined in the USP Controlled Room Temperature. The National Drug Code (NDC) for this product is 52817 332 00, and it is distributed by TruPharma, LLC, located in Tampa, FL 33609.*
FDA Label Image

Cyclobenzaprine HCl Tabs 10mg 100s

Cyclobenzaprine HCl Tabs 10mg 100s
Each film-coated tablet contains 10mg of Cyclobenzaprine Hydrochloride. The tablets are distributed by TruPharma LLC and should be stored in a tightly closed container at temperatures between 20°C to 25°C. The usual dosage and prescribing information should be followed, and the tablets should be kept out of reach of children in a light-resistant container with a child-resistant closure. The tablets are manufactured by Rubicon Research Private Limited in India. The text includes necessary information about the medicine and its distribution, storage, and safety requirements.*
FDA Label Image

Cyclobenzaprine HCl Tabs 10mg 500s

Cyclobenzaprine HCl Tabs 10mg 500s
This is a prescription medication in tablet form containing 10 mg of Cyclobenzaprine hydrochloride USP. The recommended dosage and other detailed prescribing information can be found in the accompanying instructions. The medication should be stored in a tightly closed, light-resistant container at a controlled room temperature and kept out of the reach of children. The manufacturer is Rubicon Research Private Limited located in India, and it is distributed by TruPharma Company based in Tampa, Florida. The label on the medication should read "Rx Only", followed by a specific code.*
FDA Label Image

Cyclobenzaprine HCl Tabs 5mg 100s

FDA Label Image

Cyclobenzaprine HCl Tabs 5mg 500s

Cyclobenzaprine HCl Tabs 5mg 500s
This is a medication containing Cyclobenzaprine hydrochloride USP in film-coated tablets of 5mg each. It is distributed by TruPharma LLC based in Tampa, FL. The usual dosage and prescribing information should be consulted. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure, and kept at 20°C to 25°C (68°F to 77°F). The medication should be kept out of reach of children. The manufacturer is listed as H Ambernath, Dist. Thane, but it is not available where this is located. The label indicates that there are 500 tablets.*
FDA Label Image

Cyclobenzaprine HCl Tabs 7pt5mg 100s

Cyclobenzaprine HCl Tabs 7pt5mg 100s
This is a description of a medication called Cyclobenzaprine Hydrochloride USP, which comes in the form of film-coated tablets. Each tablet contains 7.5 mg of the active ingredient. The tablets should be stored at a temperature between 20°C and 25°C and kept in a tight container out of reach of children. The medication is distributed by TruPharma LLC and the manufacturing license number is KD-682.*
FDA Label Image

Cyclobenzaprine HCl Tabs Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.